What are the Australian Standard Drug Class Screening Cut-off Levels?

Australian Standard Drug Class Screening Cut-off Levels (Australian Standard AS/NZS 4308:2023 (Urine) and AS/NZS 4760:2019 (Oral Fluid) cut-off levels are usually derived from levels which can be reliably detected in a laboratory.

Australian Standard Drug Class Screening cut-off levels may take other factors into account, such as the cut-off level for cannabis metabolites which makes allowance for passive smoking (it is set at a level that ensures a positive result cannot be obtained from passive smoking).

Urine screening – currently we are in a three year transition period with AS/NSZ 4308:2008 being replaced by AS/NZS 4308:2023. The main change is to decrease the screening cut off for cocaine metabolites from 300 ug/L down to 150 ug/L, and a corresponding drop in confirmatory cut off from 150 ug/L down to 100 ug/L resulting in more detections on site along with confirmatory testing being more likely to match the initial screening result.

The second key change in the updated urine standard is a decrease in the confirmatory cut off levels for Benzodiazepines metabolites from 200 ug/L down to 100 ug/L. This will reduce the likelihood of a non negative on site screen returning a confirmed negative confirmation due to a mixture of metabolites present in the urine with no individual component over 200 ug/L. Screening cut offs for Benzodiazepines remain at 200 ug/L.

Current drug screening cut-off levels per drug class for urine testing – AS/NZS 4308:2008

  • Amphetamine Type Stimulants (300 ug/L)
  • Benzodiazepines (200 ug/L)
  • Cannabis Metabolites (50 ug/L)
  • Cocaine Metabolites (300 ug/L) – changing to 150 ug/L with new standard 2023
  • Opiates (300 ug/L)

AS/NZS 4760:2019 (Oral Fluid)

The drug screening cut-off levels per drug class for oral fluid testing – AS/NZS 4760:2019

  • Opiates (50 ng/mL)
  • Amphetamine Type Stimulants (50 ng/mL)
  • Benzodiazepines (10 ng/mL) *
  • Cannabis (THC) (15 ng/mL)
  • Cocaine (50 ng/mL)
  • Methamphetamine (50 ng/mL)
  • Oxycodone (40 ng/mL)

 * Testing is optional for BZO based on workplaces specific testing requirements or policies.

Click here for more information regarding Australian Standards.

Related posts

Request a Demo

Talk to us for a demo or a complete customised drug testing solution, phone 1300 789 908.

You can also submit an enquiry using the following form.
Your Name(Required)
This field is for validation purposes and should be left unchanged.